Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

MBDA Score Independently Predictive of Relapsing RA

PLoS One; ePub 2018 May 23; Moghadam, et al

For patients with rheumatoid arthritis (RA) with stable low disease activity (LDA) who stopped TNF inhibitor (TNFi) treatment, a high baseline multi-biomarker disease activity (MBDA) score was independently predictive of disease relapse within 12 months. This according to a study that analyzed 439 RA patients post hoc who were randomized to stop TNFi treatment in the POET study. 3 indicators of disease relapse were assessed over 12 months: 1) restarting TNFi treatment, 2) escalation of any disease-modifying antirheumatic drug (DMARD) therapy and 3) physician-reported flare. MBDA score was assessed at baseline. Researchers found:

  • At baseline, 50.1%, 35.3%, and 14.6% of patients had low (<30), moderate (30−44), or high (>44) MBDA scores, respectively.
  • Within 12 months, 49.9% of patients had restarted TNFi medication, 59.0% had escalation of any DMARD, and 57.2% had ≥1 physician-reported flare.
  • MBDA score was associated with each indicator of relapse.
  • At least 1 indicator of relapse was observed in 59.5%, 68.4%, and 81.3% of patients with low, moderate or high MBDA scores, respectively.

Citation:

Moghadam MG, Lamers-Karnebeek FBG, Vonkeman HE, et al. Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment. [Published online ahead of print May 23, 2018]. PLoS One. doi:10.1371/journal.pone.0192425.

This Week's Must Reads

Incident Fracture, Accelerated Hip BMD Loss Linked, Osteoporos Int; ePub 2018 Jul 10; Christiansen, et al

Effect of Pre-Appointment Consult Triage Evaluated, Arthritis Care Res; ePub 2018 Jul 12; West, et al

Does Vit. D Prevent Bone Loss in Older Black Women?, J Bone Miner Res; ePub 2018 Jun 15; Aloia, et al

Gout Linked with Giant Cell Arteritis in Elderly, Joint Bone Spine; ePub 2018 Jun 7; Singh, et al

Smoking Is Risk Factor for Giant Cell Arteritis, Semin Arthritis Rheum; ePub 2018 Jul 11; Brennan, et al

Must Reads in Rheumatoid Arthritis

Hyperlipidemia Screening Poor in Persons with RA, Rheumatology (Oxford); ePub 2018 Jun 27; Schmidt, et al

Patient Confusion About Global Assessment for RA, Arthritis Care Res; ePub 2018 Jun 28; Hirsh, et al

Shared Decision-Making in RA at Point-of-Care, Arthritis Care Res; ePub 2018 Jun 28; Hsiao, et al

Examining Adiponectin Role in Rheumatoid Arthritis, PLoS One; ePub 2018 Jun 25; Hughes-Austin, et al

Online Resources for Disease Self-Management in RA, Clin Rheumatol; 2018 Jul; des Bordes, Gonzalez, et al